Examining the Link Between a Modified Cardiometabolic Index and Cardiovascular Disease Risk in Adults with Early Cardiovascular-Kidney-Metabolic Syndrome: Findings from a Prospective Cohort Study - Takeaways - MDSpire

Examining the Link Between a Modified Cardiometabolic Index and Cardiovascular Disease Risk in Adults with Early Cardiovascular-Kidney-Metabolic Syndrome: Findings from a Prospective Cohort Study

  • By

  • Hongcai Wang

  • Kaixuan Li

  • Chang Sheng

  • Xin Ye

  • Guoqiang Lin

  • March 13, 2026

  • 0 min

Share

  • 1

    The study investigates the association between the Modified Cardiometabolic Index (MCMI) and cardiovascular disease risk in adults with Cardiovascular-Kidney-Metabolic syndrome.

  • 2

    Data from 6,953 participants in the China Health and Retirement Longitudinal Study (CHARLS) were analyzed to assess cardiovascular disease incidence.

  • 3

    MCMI incorporates fasting blood glucose levels, enhancing its accuracy in reflecting risks associated with metabolic syndrome and cardiovascular diseases.

  • 4

    The American Heart Association emphasizes the importance of screening for cardiovascular risks in individuals at early stages of Cardiovascular-Kidney-Metabolic syndrome.

  • 5

    The study highlights a significant gap in research regarding the relationship between MCMI and cardiovascular events in the context of CKM syndrome.

Original Source(s)

Examining the Link Between a Modified Cardiometabolic Index and Cardiovascular Disease Risk in Adults with Early Cardiovascular-Kidney-Metabolic Syndrome: Findings from a Prospective Cohort Study

  • by Hongcai Wang, Kaixuan Li, Chang Sheng, Xin Ye, Guoqiang Lin

  • March 13, 2026

Related Content

High-fat diet-induced obesity impairs endothelium-dependent relaxation in rabbits: association with MLCK upregulation and partial ex vivo improvement by ML-7

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Association of organ dysfunction trajectories and major adverse cardiovascular events using clinical obesity in UK Biobank